{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T21:38:21.634426+00:00","company":{"ticker":"NXGL","cik":1468929,"company_name":"NEXGEL, INC."},"pagination":{"limit":100,"returned":17,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"debt_financing","fact_key":"50670d74eba0e4b28f9b12437e0ad2a0d6befb1b","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-05-15T20:31:01+00:00","payload":{"counterparty":"certain accredited investors","effective_date":"2026-05-11","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"aggregate original principal amount of $1,210,000"},"claim":"NEXGEL, INC. incurred convertible notes of aggregate original principal amount of $1,210,000 with certain accredited investors.","evidence_excerpt":"investors (the “ Buyers ”), pursuant\nto which the Company issued and sold to the Buyers (i) unsecured convertible promissory notes in the aggregate original principal amount\nof $1,210,000 (the “ Notes ”) and (ii) warrants to purchase shares of the Company’s common stock, par value\n$0.001 per share (the “ Common Stock ”), exercisable for an aggregate of 1,008,334","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-023851","anchor_url":"https://secwatch.observer/filing/0001493152-26-023851#claim-50670d74eba0e4b28f9b12437e0ad2a0d6befb1b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226023851/0001493152-26-023851-index.htm"},{"fact_type":"executive_change","fact_key":"480b888357","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-05-12T20:30:25+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-06","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kevin M. Harris was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-022503","anchor_url":"https://secwatch.observer/filing/0001493152-26-022503#claim-480b888357","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm"},{"fact_type":"executive_change","fact_key":"57d76e73b9","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-05-12T20:30:25+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-06","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Brian J. Kieser was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-022503","anchor_url":"https://secwatch.observer/filing/0001493152-26-022503#claim-57d76e73b9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm"},{"fact_type":"executive_change","fact_key":"2e2d1a9d53","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-04-27","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Ian Blackman","successor_named":true},"claim":"Adam Drapczuk resigned as Chief Financial Officer at NEXGEL, INC..","evidence_excerpt":"Mr. Blackman succeeds Mr. Drapczuk as the Company’s principal financial officer and principal accounting officer.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-020657","anchor_url":"https://secwatch.observer/filing/0001493152-26-020657#claim-2e2d1a9d53","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/0001493152-26-020657-index.htm"},{"fact_type":"executive_change","fact_key":"93d184ce56","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-04-27","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":true},"claim":"Ian Blackman was appointed as Chief Financial Officer at NEXGEL, INC..","evidence_excerpt":"the Board of Directors of the Company (the “ Board ”) appointed Ian Blackman, age 58, as Chief Financial Officer of NexGel, Inc. (the “ Company ”), effective April 27, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-020657","anchor_url":"https://secwatch.observer/filing/0001493152-26-020657#claim-93d184ce56","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/0001493152-26-020657-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"1b6383526459f70b1d8ddf4c9ea0c7276005ea12","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-24T23:59:59+00:00","payload":{"company_response":"monitoring","compliance_status":"deficient","cure_deadline":"2026-10-19","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-04-22","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)"],"rules_cited_in_text":true},"claim":"NEXGEL, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"April 22, 2026, NexGel, Inc. (the “ Company ”) received a deficiency letter from the Nasdaq Listing Qualifications\nDepartment (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the\nCompany that, for th","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018962","anchor_url":"https://secwatch.observer/filing/0001493152-26-018962#claim-1b6383526459f70b1d8ddf4c9ea0c7276005ea12","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018962/0001493152-26-018962-index.htm"},{"fact_type":"debt_financing","fact_key":"31d77a24645b1150e1fd7564b0b540a95c64d7f1","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"counterparty":"Celularity Inc.","effective_date":"2026-04-17","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"10% per annum","item_codes_triggered":["2.03"],"maturity_text":"eighteen (18) months following the issuance date","principal_text":"original principal amount of $5,000,000"},"claim":"NEXGEL, INC. incurred convertible notes of original principal amount of $5,000,000 with Celularity Inc. at 10% per annum maturing eighteen (18) months following the issuance date.","evidence_excerpt":"a convertible promissory note issued by the Company to Celularity in the original principal amount of $5,000,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018302","anchor_url":"https://secwatch.observer/filing/0001493152-26-018302#claim-31d77a24645b1150e1fd7564b0b540a95c64d7f1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018302/0001493152-26-018302-index.htm"},{"fact_type":"debt_financing","fact_key":"84330190c7c86b950bf83cb1eb76633bc35cf33f","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"counterparty":"Buyers","effective_date":"2026-04-17","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"10% per annum","item_codes_triggered":["2.03"],"maturity_text":"eighteen (18) months following the issuance date","principal_text":"aggregate original principal amount of $6,900,000"},"claim":"NEXGEL, INC. incurred convertible notes of aggregate original principal amount of $6,900,000 with Buyers at 10% per annum maturing eighteen (18) months following the issuance date.","evidence_excerpt":"the Company issued and sold to the Buyers (i) unsecured convertible promissory notes in the aggregate original principal amount of $6,900,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018302","anchor_url":"https://secwatch.observer/filing/0001493152-26-018302#claim-84330190c7c86b950bf83cb1eb76633bc35cf33f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018302/0001493152-26-018302-index.htm"},{"fact_type":"material_agreement","fact_key":"cb76574190358a1b9eeaa8c168ce83150164c550","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"notes_offering","counterparty":"certain accredited investors","effective_date":"2026-04-17","item_codes_triggered":["1.01"],"value_text":"aggregate original principal amount of $6,900,000"},"claim":"NEXGEL, INC. entered into Securities Purchase Agreement with certain accredited investors valued at aggregate original principal amount of $6,900,000 (effective 2026-04-17).","evidence_excerpt":"On April 17, 2026, the Company entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Buyers ”), pursuant to which the Company issued and sold to the Buyers (i) unsecured convertible promissory notes in the aggregate original principal amount of $6,900,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018302","anchor_url":"https://secwatch.observer/filing/0001493152-26-018302#claim-cb76574190358a1b9eeaa8c168ce83150164c550","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018302/0001493152-26-018302-index.htm"},{"fact_type":"material_agreement","fact_key":"e8f9376ac4a24402daf92cb39f34d0d948ee0c21","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment No. 1 to Asset Purchase and Exclusive License Agreement","agreement_type":"license","counterparty":"Celularity Inc.","effective_date":"2026-04-17","item_codes_triggered":["1.01"],"value_text":"aggregate consideration in the amount of $13,300,000"},"claim":"NEXGEL, INC. amended Amendment No. 1 to Asset Purchase and Exclusive License Agreement with Celularity Inc. valued at aggregate consideration in the amount of $13,300,000 (effective 2026-04-17).","evidence_excerpt":"On April 17, 2026, the Company and Celularity entered into Amendment No. 1 to the Original License Agreement (the “ Amendment ” and, together with the Original License Agreement, the “ License Agreement ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018302","anchor_url":"https://secwatch.observer/filing/0001493152-26-018302#claim-e8f9376ac4a24402daf92cb39f34d0d948ee0c21","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018302/0001493152-26-018302-index.htm"},{"fact_type":"material_agreement","fact_key":"63ba7fa8bdc36c1d32adabc762e3400dc0a68a18","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Asset Purchase and Exclusive License Agreement","agreement_type":"license","counterparty":"Celularity Inc.","effective_date":"2026-03-06","item_codes_triggered":["1.01"],"value_text":null},"claim":"NEXGEL, INC. entered into Asset Purchase and Exclusive License Agreement with Celularity Inc. (effective 2026-03-06).","evidence_excerpt":"on March 6, 2026, NexGel, Inc. (the “ Company ”) entered into an Asset Purchase and Exclusive License Agreement (the “ Original License Agreement ”) with Celularity Inc. (“ Celularity ”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018302","anchor_url":"https://secwatch.observer/filing/0001493152-26-018302#claim-63ba7fa8bdc36c1d32adabc762e3400dc0a68a18","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018302/0001493152-26-018302-index.htm"},{"fact_type":"ma_transaction","fact_key":"ad0036c2fb907d0283cc778e0ab363aea15b9ab0","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2026-04-17","consideration_text":"$13,300,000","counterparty":"Celularity Inc.","effective_date":"2026-04-17","item_codes_triggered":["2.01"]},"claim":"NEXGEL, INC. completed an acquisition involving Celularity Inc. for $13,300,000 (closed 2026-04-17).","evidence_excerpt":"the\ngrant of rights and the transfer of assets contemplated by the License Agreement, the Company agreed to pay or deliver to Celularity\naggregate consideration in the amount of $13,300,000, consisting of (i) an upfront cash payment of $8,300,000, paid on the Transaction\nCommencement Date (as defined in the License Agreement) in accordance with the flow of funds","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-018302","anchor_url":"https://secwatch.observer/filing/0001493152-26-018302#claim-ad0036c2fb907d0283cc778e0ab363aea15b9ab0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226018302/0001493152-26-018302-index.htm"},{"fact_type":"material_agreement","fact_key":"4ec0bce79702bbd3a9520dc097751c461d692206","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-03-10T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Agreement","agreement_type":"asset_purchase","counterparty":"Celularity, Inc.","effective_date":"2026-03-06","item_codes_triggered":["1.01"],"value_text":"up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million"},"claim":"NEXGEL, INC. entered into Agreement with Celularity, Inc. valued at up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million (effective 2026-03-06).","evidence_excerpt":"On March 6, 2026, NexGel, Inc., a Delaware corporation (the “ Company ”), entered into an Asset Purchase and Exclusive License Agreement (the “ Agreement ”) with Celularity, Inc., a Delaware corporation (the “ Licensor ”), whereby the Licensor granted to the Company an exclusive license to its commercial-stage biomaterials portfolio and certain development-stage programs as more fully described in the Agreement and the Licensor agreed to sell to the Company assets related to the portfolio (collectively, the “ Business ”). Consideration for the Business will consist of up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million upfront payment and (ii) an additional $20.0 million in potential milestone payments based on net sales targets related to the Business.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-009474","anchor_url":"https://secwatch.observer/filing/0001493152-26-009474#claim-4ec0bce79702bbd3a9520dc097751c461d692206","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226009474/0001493152-26-009474-index.htm"},{"fact_type":"debt_financing","fact_key":"88e9a0a2b7b95e2ddd5d2b8dd2bc3a00ff4fc8a3","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-02-11T23:59:59+00:00","payload":{"counterparty":"a certain institutional investor","effective_date":"2026-02-09","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$56,667,667"},"claim":"NEXGEL, INC. incurred convertible notes of $56,667,667 with a certain institutional investor.","evidence_excerpt":"Agreement ”)\nproviding for the purchase by the Investor of a 10% original issue discount (OID) convertible note facility in up to the aggregate original\nprincipal amount of $56,667,667 (the “ Convertible Note Facility ”), providing for the purchase by the Investor,\nin one or more closings, of (i) series A senior secured convertible notes up to an aggregate","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-006124","anchor_url":"https://secwatch.observer/filing/0001493152-26-006124#claim-88e9a0a2b7b95e2ddd5d2b8dd2bc3a00ff4fc8a3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226006124/0001493152-26-006124-index.htm"},{"fact_type":"material_agreement","fact_key":"9d36b80d6fcb3588b8b4437fc9e57bc898a2cc51","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2026-02-11T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"a certain institutional investor","effective_date":"2026-02-09","item_codes_triggered":["1.01"],"value_text":null},"claim":"NEXGEL, INC. entered into Securities Purchase Agreement with a certain institutional investor (effective 2026-02-09).","evidence_excerpt":"On February 9, 2026, NexGel, Inc., a Delaware corporation (the “ Company ”) entered into a Securities Purchase Agreement with a certain institutional investor (the “ Investor ”) named therein (the “ Purchase Agreement ”) providing for the purchase by the Investor of a 10% original issue discount (OID) convertible note facility","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-006124","anchor_url":"https://secwatch.observer/filing/0001493152-26-006124#claim-9d36b80d6fcb3588b8b4437fc9e57bc898a2cc51","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226006124/0001493152-26-006124-index.htm"},{"fact_type":"executive_change","fact_key":"b71717aaa8","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2025-01-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Joseph F. McGuire was appointed as Chief Financial Officer at NEXGEL, INC..","evidence_excerpt":"Joseph F. McGuire Appointment as Chief Financial Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-001000","anchor_url":"https://secwatch.observer/filing/0001493152-25-001000#claim-b71717aaa8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315225001000/0001493152-25-001000-index.htm"},{"fact_type":"earnings_release","fact_key":"ad176ad5710f69827be05743fd84278c73ce867a","cik":1468929,"ticker":"NXGL","company_name":"NEXGEL, INC.","filed_at":"2024-05-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$905,000","period_text":"the quarter ended March 31, 2024","report_date":"2024-05-13","result_type":"reported_results","revenue_text":"$1.27 million"},"claim":"NEXGEL, INC. reported the quarter ended March 31, 2024 results: revenue $1.27 million, net income $905,000.","evidence_excerpt":"as shall be expressly set forth by specific reference in such a filing. \n\n--- EX-99.1 () ---\n\nEX-99.1 2 ex99-1.htm Exhibit\n99.1 NEXGEL\nReports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year LANGHORNE,\nPa. – May 13, 2024 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a\nleading provider of ultra-gentle,","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-018955","anchor_url":"https://secwatch.observer/filing/0001493152-24-018955#claim-ad176ad5710f69827be05743fd84278c73ce867a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315224018955/0001493152-24-018955-index.htm"}]}